-
Product Insights
Guangxi Gov – Guangxi Napo County Global Tourism PPP Project – Guangxi Zhuang Autonomous Region
Equip yourself with the essential tools needed to make informed and profitable decisions with our Guangxi Gov - Guangxi Napo County Global Tourism PPP Project - Guangxi Zhuang Autonomous Region report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
Guangxi Communications – Wuzhou-Napo Highway: Pingguo-Napo Section – Guangxi Zhuang Autonomous Region
Equip yourself with the essential tools needed to make informed and profitable decisions with our Guangxi Communications - Wuzhou-Napo Highway: Pingguo-Napo Section - Guangxi Zhuang Autonomous Region report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness, and diarrhea. Complications of short bowel syndrome include malnutrition, peptic ulcers, kidney stones, and small intestinal bacterial overgrowth. Treatment includes vitamin and mineral supplements, antibiotics, proton pump inhibitors, and bile-salt binders The Short Bowel Syndrome pipeline drugs market research report provides comprehensive information on...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – crofelemer DR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry crofelemer DR Drug Details Crofelemer (Fulyzaq, Mytesi) is an anti diarrheal agent. It is...
-
Product Insights
Irritable Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of irritable bowel syndrome include cramping, abdominal pain, bloating gas, diarrhea, backache, muscle pains, poor appetite, and constipation. These symptoms can be triggered by food, stress, and hormones. The Irritable Bowel Syndrome pipeline market research report provides comprehensive information on the therapeutics under development for Irritable Bowel Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cholera pipeline market research report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cholera and features dormant and discontinued projects.
-
Product Insights
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels, and incontinence. Treatment includes medication and a healthy lifestyle. The Diarrhea Drugs in Development market research report provides an overview of the diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics...
-
Sector Analysis
Supportive Care in Cancer – Comprehensive Overview, Pipeline Products, Research and Development Strategies and Unmet Needs
Supportive care in cancer is an evolving discipline of medicine that is critical for holistic management of patients with cancer. With significant advancements being made in treatment of cancer particularly through development of immuno-oncology (IO) and targeted therapies, it is of equal significance to focus on supportive care in cancer so as to ensure that patients are able to complete the treatment cycle for the primary cancer as well as to enhance their quality of life. The report leverages on...
-
Product Insights
Diarrhea Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2019" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
PharmaPoint: Irritable Bowel Syndrome(IBS) – Global Drug Forecast and Market Analysis to 2026
Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months. IBS is classified into three main subtypes, according to the predominant bowel habit: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and mixed-presentation (IBS-M) IBS. The IBS treatment landscape remains largely underserved, and ample opportunity exists for pharmaceutical companies to address the...